entertainment -WSS

entertainment

author：focus 2025-09-14 18:30:55 - browse：577

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Websites selling Wegovy, Zepbound ingredients targeted by FDA

WSS

How to address the problem of discarded donor organs

Too many hospitalized Covid

Congress considering partial increase for doctor pay in Medicare

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Biotech companies concerned about China biosecurity crackdown

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

focus

entertainment

focus

The cancer drug shortage isn’t new — and neither are the solutions

Pfizer highlights cancer drugs it thinks could reignite investor interest

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Change Healthcare cyberattack outage could last weeks

How to save PrEP access — and even expand it

RSV vaccines may be linked to small increased risk of developing GBS

Bright Health sells Medicare Advantage business to Molina

Congress might make insulin pumps more accessible to the blind

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pfizer highlights cancer drugs it thinks could reignite investor interest

entertainment

Congress considering partial increase for doctor pay in Medicare

ALS groups 'won't be played again' by the FDA, drug sponsors

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Flu vaccine offering decent levels of protection this winter, new data show

Clinical trials giant ICON acquires HumanFirst

Obesity now affects over 1 billion people worldwide, study finds

hotspot

focus

hotspot

leisure time